---
title: "Hanvon Technology: Provides joint liability guarantee for a loan of 5 million yuan for its holding subsidiary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263751798.md"
description: "Hanvon Technology announced that it has provided a joint liability guarantee for a loan of 5 million yuan to its wholly-owned subsidiary, Hanvon Health. The subsidiary has signed a loan contract with the Zhongguancun Branch of Bank of Beijing and has signed a maximum guarantee contract. Hanvon Health is 100% owned by the company, with a debt-to-asset ratio of 95.71%. Currently, the company's guarantee balance for its subsidiaries is 113 million yuan, accounting for 9.90% of the most recent audited net assets"
datetime: "2025-10-31T12:48:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263751798.md)
  - [en](https://longbridge.com/en/news/263751798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263751798.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263751798.md) | [繁體中文](https://longbridge.com/zh-HK/news/263751798.md)


# Hanvon Technology: Provides joint liability guarantee for a loan of 5 million yuan for its holding subsidiary

Hanvon Technology announced that the company plans to provide a guarantee of no more than 300 million yuan for its subsidiaries within the scope of consolidated financial statements. Recently, its holding subsidiary Hanvon Health signed a loan contract of 5 million yuan with the Zhongguancun branch of Bank of Beijing, and the company signed a maximum guarantee contract for this loan, providing joint liability guarantee. Hanvon Health is 100% owned by the company, with a debt-to-asset ratio of 95.71% as of September 30, 2025. As of now, the company's guarantee balance for its subsidiaries is 113 million yuan, accounting for 9.90% of the most recent audited net assets, with no overdue or litigated guarantees

### Related Stocks

- [Hanvon (002362.CN)](https://longbridge.com/en/quote/002362.CN.md)

## Related News & Research

- [08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health](https://longbridge.com/en/news/277468910.md)
- [UK government-owned BII targets controlling stake in Zambia's Zambeef](https://longbridge.com/en/news/277622046.md)
- [14:32 ETCognizin® Citicoline Powers Happy Panda™'s New Functional Energy Drink Launch](https://longbridge.com/en/news/277511128.md)
- [08:00 ETBluesight Partners with GraphiteRx and Mark Cuban Cost Plus Drugs to Expand Access to Cost-Saving Medication Sources](https://longbridge.com/en/news/277625153.md)
- [Webasto unveils roof-mounted AC system for light commercial EVs](https://longbridge.com/en/news/277626749.md)